期刊文献+

不同浓度牡蛎蛋白肽对大鼠骨髓间充质干细胞增殖和分化能力的影响 被引量:4

Effects of oyster protein peptide with different concentrations on the proliferation and differentiation of bone marrow mesenchymal stem cells
下载PDF
导出
摘要 目的:探讨不同浓度牡蛎蛋白肽对骨髓间充质干细胞(bone marrow mesenchymal stem cells,BMSCs)成骨分化的影响。方法:选择具备稳定传代能力的第3代大鼠BMSCs,采用MTT试剂盒,检测细胞在0、10、20、50 mg/L不同牡蛎蛋白肽浓度干预培养24 h、3 d、7 d后的细胞活力。然后将BMSCs分为普通培养基组(DMEM)和成骨诱导培养基组(ODM),根据牡蛎蛋白肽的不同浓度,将实验组分为4组,依次为0、10、20、50 mg/L,利用碱性磷酸酶(ALP)染色法和ALP半定量检测法,研究不同浓度牡蛎蛋白肽对BMSCs培养10 d早期成骨分化的影响。应用茜素红染色法,半定量检测不同浓度牡蛎蛋白肽对BMSCs培养21 d后成骨矿化的影响,应用RT-PCR检测成骨相关基因的表达情况。采用SPSS 20.0软件包对数据进行统计学分析。结果:MTT结果表明,经不同浓度药物干预处理后,细胞活力旺盛,无明显异常;但牡蛎蛋白肽药物浓度为50 mg/L时,细胞死亡数有上升趋势。ALP半定量检测结果显示,DMEM和ODM组诱导分化第10天时,20 mg/L浓度组的ALP活性显著高于对照组(P<0.05),50 mg/L浓度组的ALP活性与对照组无显著差异。茜素红半定量检测结果显示,ODM组中20 mg/L实验组的A值显著高于对照组(P<0.05)。与对照组及50 mg/L组相比,10、20 mg/L组RUNX-2和OCN的表达显著上升(P<0.05)。结论:高于50 mg/L浓度的牡蛎蛋白肽对BMSCs的成骨分化表现出明显抑制作用,而低浓度牡蛎蛋白肽,尤其是20 mg/L的牡蛎蛋白肽对BMSCs成骨分化及细胞生长有促进作用。 PURPOSE: To investigate the effect of different concentrations of oyster protein peptide on osteogenic differentiation of bone marrow mesenchymal stem cells(BMSCs). METHODS: BMSCs of the third generation from rats with stable subculture ability were selected, and the cell viability was detected by MTT kit at different concentrations of 0,10, 20 and 50 mg/L oyster protein peptide for 24 hours, 3 days and 7 days. BMSCs were divided into two groups: cultured with DMEM or ODM. According to the different concentrations of oyster protein peptide, the experimental groups were divided into four subgroups, which were 0, 10, 20 and 50 mg/L, respectively. The effects of different concentrations of oyster protein peptide on the early osteogenic differentiation of BMSCs were evaluated by ALP staining and ALP semiquantitative detection. Alizarin red staining was used to detect the effect of different concentrations of oyster protein peptide on the osteogenesis and mineralization of BMSCs after 21 days of treatment. RT-PCR was used to defect the expression of bone formation-related genes. SPSS 20.0 software package was used to analyze the data. RESULTS: The results of MTT showed that cell activity was vigorous and there was no obvious abnormality after intervention with different concentrations of drugs, but the number of cell death increased when the concentration of oyster protein peptide was 50 mg/L. The results of ALP semi-quantitative analysis showed that ALP activity of DMEM and ODM group was significantly higher than that of the control group(P<0.05) on the 10 th day of differentiation induction, but there was no significant difference between 50 mg/L group and the control group. Alizarin red semi-quantitative analysis showed that the A value of 20 mg/L in ODM group was significantly higher than that of the control group(P<0.05). The expression of RUNX-2 and OCN in 10 mg/L and 20 mg/L groups were significantly higher than that in control goup and 50 mg/L group(P<0.05).CONCLUSIONS: Oyster protein peptide with a concentration higher than 50 mg/L can significantly inhibit osteogenic differentiation of BMSCs, while oyster protein peptide with a low concentration, especially oyster protein peptide with a concentration of 20 mg/L, can promote osteogenic differentiation and cell growth of BMSCs.
作者 王毅炜 李晨琳 蒋倩 徐光宙 WANG Yi-wei;LI Chen-lin;JIANG Qian;XU Guang-zhou(Department of Oral Medicine,Huaian Stomatological Hospital.Huaian 223300,Jiangsu Province;Department of Oral Surgery,Shanghai Ninth People’s Hospital,College of Stomatology,Shanghai Jiao Tong University School of Medicine/National Clinical Research Center for Oral Diseases,Shanghai Key Laboratory of Stomatology&Shanghai Research Institute of Stomatology.Shanghai 200011,China)
出处 《中国口腔颌面外科杂志》 CAS 2021年第1期6-11,共6页 China Journal of Oral and Maxillofacial Surgery
基金 国家自然科学基金(31800816) 浦东新区卫生和计划生育委员会卫生计生科研项目(PW2018D-08) 上海申康医院发展中心临床科技创新项目-市级医院新兴前沿技术联合攻关项目(SHDC12019X01) 上海交通大学医学院附属第九人民医院创客基金(CK2018002)。
关键词 牡蛎蛋白肽 干细胞 成骨分化 中药 Oyster protein peptide Stem cell Osteogenic differentiation Traditional Chinese medicine
  • 相关文献

参考文献6

二级参考文献50

  • 1曾利荣,张尔贤.牡蛎的食用与药用价值及其开发利用[J].自然杂志,1998,20(6):322-325. 被引量:20
  • 2MURANO T, IZUMI S, KIKA G, et al. Impact of menopause on lipid and bone metabolism and effect of hormone replacement therapy[J]. Tokai J Exp Clin Med, 2003 , 28(3): 109-119.
  • 3MOORE M, BRACKER M, SARTORIS D, et al. Long-term estrogen replacement therapy in postmenopausal women sustains vertebral bone mineral density[J]. Bone Miner Res, 1990, 5(6): 659-664.
  • 4STAREN ED, OMER S. Hormone replacement therapy in postmenopausal women[J]. Am J Surg, 2004, 188(2) : 136-149.
  • 5ALEXANDERSEN P, TOUSSAINT A, CHRISTIANSEN C, et al. Ipriflavone in the treatment of postmenopausal osteoporosie : a randomized controlled trial[J]. JAMA, 2001, 285 (11) : 1482- 1488.
  • 6ARJMANDI BH, BIRNBAUM RS, JUMA S, et al. The synthetic phytoestrogen, ipriflavone, and estrogen prevent bone loss by different mechanisms[J]. Calcif Tissue Int, 2000, 66(1): 61-65.
  • 7DEYHIM F, SMITH BJ, SOUNG DY, et al. Ipriflavone modulates IGF-1 but is unable to restore bone in rats[J]. Phytother Res,2005, 19(2): 116-120.
  • 8PICHERIT C, CHANTERANNE B, BENNETAU-PELISSERO C, et al. Dose-dependent bone-sparing effects of dietary isoflavones in the ovariectomized rat[J]. Br J Nutr, 2001, 85 (3): 307-316.
  • 9ARJMANDI BH, ALEKEL L, HOLL/S BW, et al. Dietary soybean protein prevents bone loss in an ovarieetomized rat model of osteoporosis[J]. J Nutr, 1996, 126(1) : 161-167.
  • 10王惠英,孙涛,周冬香,毛芳.美拉德反应产物抗氧化性能研究进展[J].食品科技,2007,32(8):12-15. 被引量:29

共引文献50

同被引文献90

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部